# Novartis Sets 5% Annual Net Sales Growth Target Through 2031

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/61339
Published: 2026-11-19T12:59:11.000Z
Updated: 2026-11-19T12:59:11.000Z
Section: Business

> The foreign exchange-adjusted target covers 2026 to 2031. Novartis shares fell in Zurich after the company updated its midterm outlook.

Novartis set a foreign exchange-adjusted target for net sales to grow at a 5% compound annual rate from 2026 through 2031, while its shares fell in Zurich after the Swiss drugmaker updated its midterm outlook on Nov. 19.


